Cargando…

Pleiotropic effects of sitagliptin versus voglibose in patients with type 2 diabetes inadequately controlled via diet and/or a single oral antihyperglycemic agent: a multicenter, randomized trial

PURPOSE: A step-up strategy for diet therapy and/or single oral antihyperglycemic agent (OHA) regimens has not yet been established. The aim of this study was to evaluate hemoglobin A1c (HbA1c) as a primary end point, and the pleiotropic effects on metabolic and cardiovascular parameters as secondar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsushima, Yukiko, Takeshita, Yumie, Kita, Yuki, Otoda, Toshiki, Kato, Ken-ichiro, Toyama-Wakakuri, Hitomi, Akahori, Hiroshi, Shimizu, Akiko, Hamaguchi, Erika, Nishimura, Yasuyuki, Kanamori, Takehiro, Kaneko, Shuichi, Takamura, Toshinari
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2016
Materias:	Clinical Care/Education/Nutrition/Psychosocial Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838664/ https://www.ncbi.nlm.nih.gov/pubmed/27110370 http://dx.doi.org/10.1136/bmjdrc-2015-000190

Ejemplares similares

Vildagliptin vs liraglutide as a second-line therapy switched from sitagliptin-based regimens in patients with type 2 diabetes: A randomized, parallel-group study
por: Takeshita, Yumie, et al.
Publicado: (2015)

Metabolic and sympathovagal effects of bolus insulin glulisine versus basal insulin glargine therapy in people with type 2 diabetes: A randomized controlled study
por: Takeshita, Yumie, et al.
Publicado: (2020)

Sitagliptin versus mitiglinide switched from mealtime dosing of a rapid-acting insulin analog in patients with type 2 diabetes: a randomized, parallel-group study
por: Takeshita, Yumie, et al.
Publicado: (2015)

Sitagliptin added to voglibose monotherapy improves glycemic control in patients with type 2 diabetes
por: Tajima, Naoko, et al.
Publicado: (2013)

Study Protocol for Pleiotropic Effects and Safety of Sodium–Glucose Cotransporter 2 Inhibitor Versus Sulfonylurea in Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
por: Takeshita, Yumie, et al.
Publicado: (2020)

Effects of metformin and alogliptin on body composition in people with type 2 diabetes
por: Takeshita, Yumie, et al.
Publicado: (2018)

Efficacy and safety of sitagliptin added to metformin and insulin compared with voglibose in patients with newly diagnosed type 2 diabetes
por: Shi, Chunhong, et al.
Publicado: (2019)

Linagliptin monotherapy compared with voglibose monotherapy in patients with type 2 diabetes undergoing hemodialysis: a 12-week randomized trial
por: Mori, Katsuhito, et al.
Publicado: (2016)

Pleiotropic Effects of Sitagliptin in the Treatment of Type 2 Diabetes Mellitus Patients
por: Kubota, Akira, et al.
Publicado: (2012)

Comparison of effects of sitagliptin and voglibose on left ventricular diastolic dysfunction in patients with type 2 diabetes: results of the 3D trial
por: Oe, Hiroki, et al.
Publicado: (2015)

Pancreatic Safety of Sitagliptin in the TECOS Study
por: Buse, John B., et al.
Publicado: (2017)

Influence of depression on racial and ethnic disparities in diabetes control
por: Breland, Jessica Y, et al.
Publicado: (2023)

Pharmacokinetic study of metformin to compare a voglibose/metformin fixed-dose combination with coadministered voglibose and metformin
por: Choi, Hyang-Ki, et al.
Publicado: (2015)

Mealtime dosing of a rapid-acting insulin analog reduces glucose variability and suppresses daytime cardiac sympathetic activity: a randomized controlled study in hospitalized patients with type 2 diabetes
por: Kanamori, Takehiro, et al.
Publicado: (2018)

Diabetic Patients’ Medication Underuse, Illness Outcomes, and Beliefs About Antihyperglycemic and Antihypertensive Treatments
por: Aikens, James E., et al.
Publicado: (2009)

Comparison of Acarbose and Voglibose in Diabetes Patients Who Are Inadequately Controlled with Basal Insulin Treatment: Randomized, Parallel, Open-Label, Active-Controlled Study
por: Lee, Mi Young, et al.
Publicado: (2014)

Ursodeoxycholic acid potentiates dipeptidyl peptidase-4 inhibitor sitagliptin by enhancing glucagon-like peptide-1 secretion in patients with type 2 diabetes and chronic liver disease: a pilot randomized controlled and add-on study
por: Shima, Kosuke Robert, et al.
Publicado: (2018)

Proteasome Dysfunction Mediates Obesity-Induced Endoplasmic Reticulum Stress and Insulin Resistance in the Liver
por: Otoda, Toshiki, et al.
Publicado: (2013)

Role of Intestinal Microbiota in Metabolism of Voglibose In Vitro and In Vivo
por: Nepal, Mahesh Raj, et al.
Publicado: (2020)

Effects of combination therapy with mitiglinide and voglibose on postprandial plasma glucose in patients with type 2 diabetes mellitus
por: Konya, Hiroyuki, et al.
Publicado: (2013)

Effect of Exenatide, Sitagliptin, or Glimepiride on β-Cell Secretory Capacity in Early Type 2 Diabetes
por: Gudipaty, Lalitha, et al.
Publicado: (2014)

Comparison of efficacy of concomitant administration of mitiglinide with voglibose and double dose of mitiglinide in patients with type 2 diabetes mellitus
por: Katsuno, Tomoyuki, et al.
Publicado: (2010)

Somatostatin Receptor-negative and Fluorodeoxyglucose-positron Emission Tomography-positive Lung Neuroendocrine Tumor G1 Exhibiting Cyclic Cushing's Syndrome
por: Nomura, Chiaki, et al.
Publicado: (2022)

Fat‐free mass and calf circumference as body composition indices to determine non‐exercise activity thermogenesis in patients with diabetes
por: Isobe, Yuki, et al.
Publicado: (2015)

Metformin Prevents and Reverses Inflammation in a Non-Diabetic Mouse Model of Nonalcoholic Steatohepatitis
por: Kita, Yuki, et al.
Publicado: (2012)

Serum selenoprotein P, but not selenium, predicts future hyperglycemia in a general Japanese population
por: Oo, Swe Mar, et al.
Publicado: (2018)

Impact of Voglibose on the Pharmacokinetics of Dapagliflozin in Japanese Patients with Type 2 Diabetes
por: Imamura, Akira, et al.
Publicado: (2013)

The effects of the voglibose on non-alcoholic fatty liver disease in mice model
por: Bae, Jaehyun, et al.
Publicado: (2022)

Efficacy and Safety of Dulaglutide Versus Sitagliptin After 52 Weeks in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-5)
por: Nauck, Michael, et al.
Publicado: (2014)

Efficacy and safety of ipragliflozin in Japanese patients with type 2 diabetes and inadequate glycaemic control on sitagliptin
por: Kaku, Kohei, et al.
Publicado: (2021)

Community-based organizations are critical partners in providing complete cancer care
por: Rutledge, R., et al.
Publicado: (2009)

Klinefelter syndrome as a window on the aetiology of language and communication impairments in children: the neuroligin–neurexin hypothesis
por: Bishop, Dorothy VM, et al.
Publicado: (2011)

Adverse effect of long work hours on incident diabetes in 7065 Ontario workers followed for 12 years
por: Gilbert-Ouimet, Mahée, et al.
Publicado: (2018)

Patients’ perspectives on social and goal-based comparisons regarding their diabetes health status
por: Martinez, William, et al.
Publicado: (2018)

Psychometric testing of the Norwegian Diabetes Health Profile (DHP-18) in patients with type 1 diabetes
por: Jelsness-Jørgensen, Lars-Petter, et al.
Publicado: (2018)

Self-monitoring of blood glucose in insulin-treated diabetes: a multicase study
por: Cameron, Dawn, et al.
Publicado: (2018)

Self-efficacy and diabetes prevention in overweight South Asians with pre-diabetes
por: Cioffi, Catherine E, et al.
Publicado: (2018)

Differences in emotional responses in living and deceased donor kidney transplant patients
por: Zimmermann, Tanja, et al.
Publicado: (2016)

Patient's perceptions of chronic kidney disease and their association with psychosocial and clinical outcomes: a narrative review
por: Clarke, Amy L., et al.
Publicado: (2016)

Caregiver word reading literacy and health outcomes among children treated in a pediatric nephrology practice
por: Rak, Eniko C., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qchakq1k8ep10ob9qc2n9b24m1